rationalskepticism.org

Alzheimer's treatment within reach after successful drug trial
Tablet that ‘switches off’ production of toxic amyloid proteins could be first treatment licensed in a decade if it is also shown to slow mental decline

Trial shows tantalising signs that new Alzheimer's drug could benefit early-stage patients
Injections of the antibody aducanumab appear to slow condition in patients at earliest stages of disease, raising hopes for treatment